Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lorna Clark

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|April 3, 2021
Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I AssayPeter A Kavsak, Lorna Clark, Janet Martin, et al.
JMIR Research Protocols|January 18, 2015
An integrated web-based mental health intervention of assessment-referral-care to reduce stress, anxiety, and depression in hospitalized pregnant women with medically high-risk pregnancies: a feasibility study protocol of hospital-based implementationDawn Kingston, Selikke Janes-Kelley, Janie Tyrrell, et al.
Journal of Cardiovascular Development and Disease|April 3, 2021
Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency SettingPeter A Kavsak, Shawn E Mondoux, Janet Martin, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|January 17, 2018
Studies of Transgenic Mosquitoes in Disease-Endemic Countries: Preparation of Containment FacilitiesM Megan Quinlan, James Mutuku Mutunga, Abdoulaye Diabaté, et al.
Journal of Immunological Methods|December 3, 2013
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responsesMarloes A Naarding, Natalia Fernandez, John C Kappes, et al.
Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.
Plos One|May 12, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African AdultsGloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
Plos One|December 24, 2010
Equivalence of ELISpot assays demonstrated between major HIV network laboratoriesDilbinder K Gill, Yunda Huang, Gail L Levine, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|April 3, 2021
Acute Phase Response and Non-Reproducible Elevated Concentrations with a High-Sensitivity Cardiac Troponin I AssayPeter A Kavsak, Lorna Clark, Janet Martin, et al.
JMIR Research Protocols|January 18, 2015
An integrated web-based mental health intervention of assessment-referral-care to reduce stress, anxiety, and depression in hospitalized pregnant women with medically high-risk pregnancies: a feasibility study protocol of hospital-based implementationDawn Kingston, Selikke Janes-Kelley, Janie Tyrrell, et al.
Journal of Cardiovascular Development and Disease|April 3, 2021
Disagreement between Cardiac Troponin Tests Yielding a Higher Incidence of Myocardial Injury in the Emergency SettingPeter A Kavsak, Shawn E Mondoux, Janet Martin, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|January 17, 2018
Studies of Transgenic Mosquitoes in Disease-Endemic Countries: Preparation of Containment FacilitiesM Megan Quinlan, James Mutuku Mutunga, Abdoulaye Diabaté, et al.
Journal of Immunological Methods|December 3, 2013
Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responsesMarloes A Naarding, Natalia Fernandez, John C Kappes, et al.
Journal of Immunological Methods|June 15, 2011
Measuring human T cell responses in blood and gut samples using qualified methods suitable for evaluation of HIV vaccine candidates in clinical trialsHarry Kaltsidis, Hannah Cheeseman, Jakub Kopycinski, et al.
Clinical and Vaccine Immunology : CVI|January 25, 2013
Safety and immunogenicity of DNA prime and modified vaccinia ankara virus-HIV subtype C vaccine boost in healthy adultsPeter Hayes, Jill Gilmour, Andrea von Lieven, et al.
Plos One|May 12, 2015
A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African AdultsGloria Omosa-Manyonyi, Juliet Mpendo, Eugene Ruzagira, et al.
Plos One|August 8, 2012
A phase I double blind, placebo-controlled, randomized study of a multigenic HIV-1 adenovirus subtype 35 vector vaccine in healthy uninfected adultsMichael C Keefer, Jill Gilmour, Peter Hayes, et al.
Plos One|December 24, 2010
Equivalence of ELISpot assays demonstrated between major HIV network laboratoriesDilbinder K Gill, Yunda Huang, Gail L Levine, et al.
Pageof 3